Maky Zanganeh is Director at Pulse Biosciences, Inc. (PLSE). They have made 18 open-market trades across 3 companies since 2013, most recently 2022-08-16.
15 open-market purchases totalling $20.7M since 2017, against 3 sales. Across 15 scored buys the stock is up 14.9% at ninety days, and 11.3 points ahead of the S&P over the same stretch.
15 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 73% | 73% | 73% |
| Avg Move | +13.7% | +22.2% | +14.9% |
| Alpha | +13.6% | +20.8% | +11.3% |
| Scored | 15 | 15 | 15 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SMMT | BUY | 2022-08-16 | 2022-08-18 | $0.97 | $11.3M | -10.0% | -6.2% | -20.0% |
| SMMT | BUY | 2021-05-12 | 2021-05-14 | $5.24 | $4.1M | +35.4% | +9.7% | +31.3% |
| PLSE | BUY | 2020-06-23 | 2020-06-25 | $10.70 | $13K | +4.0% | +8.0% | +6.1% |
| PLSE | BUY | 2020-06-17 | 2020-06-19 | $7.01 | $111K | +1.5% | +16.2% | +24.1% |
| PLSE | BUY | 2017-12-13 | 2017-12-15 | $23.98 | $26K | -3.5% | -7.1% | -42.0% |
| PLSE | BUY | 2017-12-11 | 2017-12-13 | $23.07 | $92K | -5.9% | -10.0% | -34.9% |
| PLSE | BUY | 2017-09-14 | 2017-09-18 | $13.70 | $515K | +23.9% | +45.0% | +56.8% |
| PLSE | BUY | 2017-08-02 | 2017-08-04 | $24.23 | $898K | -9.2% | -18.4% | -5.2% |
| PLSE | BUY | 2017-05-11 | 2017-05-11 | $20.84 | $313K | +27.0% | +34.8% | +8.1% |
| PLSE | BUY | 2017-05-10 | 2017-05-11 | $21.71 | $109K | +27.0% | +34.8% | +8.1% |
| PLSE | BUY | 2017-05-09 | 2017-05-11 | $20.16 | $681K | +27.0% | +34.8% | +8.1% |
| PLSE | BUY | 2017-05-09 | 2017-05-11 | $20.36 | $1.8M | +27.0% | +34.8% | +8.1% |
| PLSE | BUY | 2017-03-17 | 2017-03-20 | $23.24 | $499K | +16.0% | +10.0% | +61.4% |
| PLSE | BUY | 2017-02-15 | 2017-02-22 | $11.97 | $156K | +3.6% | +108.2% | +93.8% |
| PLSE | BUY | 2017-02-14 | 2018-03-28 | $12.13 | $190K | +42.2% | +37.8% | +20.4% |
| PCYC | SELL | 2015-03-11 | 2015-03-16 | $254.11 | $7.6M | N/A | N/A | N/A |
| PCYC | SELL | 2014-11-07 | 2014-11-12 | $134.69 | $4.1M | N/A | N/A | N/A |
| PCYC | SELL | 2013-12-16 | 2013-12-18 | $107.55 | $2.2M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.